RxDoctor Payments Data

Rachel Nutting

Physician Assistant · Caldwell, IDNPI 1437403441

Payments from drug & device makers

$1,072in general payments, 2019–2025

Across 60 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$264
  • Pfizer$198
  • Amgen$92
  • Edwards Lifesciences$82
  • E.r. Squibb & Sons, L.L.C.$71
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$69
  • plus $297 from 9 others

What the payments were for

  • Food & beverage$1,072100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,072 in reported general payments places this provider in the 70th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$55,802
Medicare patients
285
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban197$177,283
FarxigaDapagliflozin Propanediol169$164,840
JardianceEmpagliflozin152$153,157
XareltoRivaroxaban54$52,730
EntrestoSacubitril/Valsartan44$50,723
Repatha SureclickEvolocumab65$40,025
BrilintaTicagrelor16$16,463
Metoprolol Succinate331$4,009
Ranolazine ErRanolazine41$4,001
Atorvastatin Calcium343$3,555
Bumetanide65$3,133
Potassium Chloride173$2,939
Torsemide58$2,554
Candesartan Cilexetil51$2,480
Eplerenone23$2,159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$65$181,303185 claims
PfizerEliquis$198$177,283197 claims
Boehringer IngelheimJardiance$35$153,157152 claims
Johnson & JohnsonXarelto$67$52,73054 claims
NovartisEntresto$264$50,72344 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Caldwell

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →